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We have recently defined  a  mouse strain,  B6.C-H-2  brat2 (bml2),  which  carries a 
mutation in the I-A subregion of the H-2 complex (1). The mutation has resulted in: 
(a)  an alteration in the serologically detected specificities Ia-3,8,9,15, and 20,  (coded 
for by Ia-1);  (b)  skin graft rejection  (H-2IA)  between parent and mutant;  and  (c)  a 
strong mixed lymphocyte reaction between parent and mutant  (Lad-l)  (1,  2).  As all 
three moieties were altered by the same mutation, the presumption was that the three 
genes were identical. The occurrence of this mutant strain provides an opportunity to 
examine the relationship between different phenomena coded for by I region genes-- 
in particular to determine whether Ir genes and genes coding for the Ia specificities 
are the same. We have therefore examined the response to several defined antigens: 
poly(LTyr, LGlu)-poly(DLAla)--poly(LLys) [(T,G)-A--L], poly(Phe,Glu)poly(DLAla)-- 
poly(LLys) [(Phe,G)-A--L], poly(His,Glu)-poly(vLAla)--poly(LLys) [(H,G)-A--L], and 
to the male-specific H-Y antigen--all antigens being totally or partially under control 
of/r genes mapping in the I-A subregion (3, 4). In brief, the antibody responses to the 
synthetic polypeptide antigens were the same in C57BL/6 and in bm 12; by contrast, 
bml2 female mice were unable to generate cytotoxic T  cells  (Tc)  in response to the 
male H-Y antigen, whereas C57BL/6 females reproducibly made a good response. 
Materials and Methods 
To generate anti-H-Y cytotoxic cells, female mice were primed by an intraperitoneal injection 
of 10  r male spleen cells (in 0.2 ml phosphate-buffered saline [PBS]), then boosted in vitro 2 wk- 
2 mo later (4, 5). Spleen cells (10  s) from primed female mice were stimulated with x-irradiated 
(1,500 rad) male spleen  cells in 20 ml culture medium in upright Costar 3050 flasks (Costar, 
Data Packaging, Cambridge, Mass.) for 5 d at 37°C in a humidified 10% CO2 atmosphere. The 
culture medium consisted  of RPMI-1640 medium (Flow Laboratories, Inc., Rockville,  Md.), 
supplemented with 2% heat-inactivated human serum, 20-raM Hepes buffer, 2 mM L-gluta- 
mine,  100 pg/ml streptomycin,  100 IU/ml penicillin,  and  5  ×  10  -5 M  2-mereaptoethanol. 
Target cells used in the cell-mediated lysis (CML) assay were prepared by stimulating spleen 
cells (5 ×  106/ml) with 2/~g/ml concanavalin A (ConA) (Pharmaeia Fine Chemicals, Uppsala, 
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Sweden)  in 50 ml of culture medium in  75-cm  2 flasks (Lux Scientific Corp., Newbury Park, 
Calif.). After an  incubation time of 2  d  at  37°C  in  10%  CO2,  the blast cells were  isolated 
on  Ficoll-Paque (1.077  g/ml), washed  twice, and resuspended in  RPMI-1640  medium with 
10%  fetal calf serum  (FCS).  10  e target cells in 0.5 mi RPMI-FCS were labeled with 300/tCi 
Naz[SLCr]O4 (Radiochemical Centre, Amersham, England)  for 90 min at 37°C,  then washed 
three times, and resuspended to 2 ×  105/ml. For the CML assay, Tc generated in vitro were 
harvested, washed twice, and  resuspended in  RPMI-FCS. Graded numbers of Tc  in  100 pl 
were mixed with  100/d  of target cells (2  ×  104) in round-bottomed Cooke microtiter plates 
(Cooke Engineering Co., Alexandria, Va.). After a  4-h incubation at 37°C  in  10% CO2,  100 
/d of the supernate was harvested from each well and the radioactivity measured in a gamma 
counter (Packard Instrument Co., Inc., Downers Grove, Ill.). All experiments were set up in 
triplicate. The specific 5~Cr release was calculated as: 
percent 5aCr release of test -  percent spontaneous release 
percent specific release = 
percent maximum release -  percent spontaneous release 
The spontaneous and maximum 5aCr release were determined by incubating target cells with 
medium or 1% Nonidet P-40, respectively. 
The antibody responses of the parental C57BL/6 and the mutant bm 12 mice were examined 
by immunizing mice with  10 #g/ml  (T,G)-A--L, (Phe,G)-A--L, and  (H,G)-A--L (Miles-Yeda 
Ltd., Rehovot, Israel) in Freund's adjuvant (6, 7). Individual mice were bled and tested in an 
indirect antibody binding radioiummune assay for antibody activity. Polyvinylchloride plates 
(Cooke Engineering Co.)  were coated with 25/tl of antigen  (at  100/.tg/ml in PBS)  at room 
temperature for 1 h, after which the plates were washed four times with PBS that contained 2% 
bovine serum albumin and 0.06% sodium azide. Doubling dilutions of 25/~1 of antiserum were 
added to the plates, and these were incubated at 37°C  for  1 h, then at 4°C overnight, and 
subsequently washed four times. II2~-protein A (Pharmacia Fine Chemicals) in 25 pl was added 
to each well, the plates incubated for 1 h at 4°C, washed five times, dried, and then cut using 
a hot wire. The individual wells were counted for radioactivity. Protein-A was iodinated by the 
chloramine T  method. 
Results 
Antibody  Response  to  (T,G)-A--L,  (Phe, G)-A--L,  and  (H,G)-A--L.  Groups  of 5-10 
mice were immunized with the above-mentioned antigens and their antibody response 
measured by the protein-A binding assay. The results are shown in Table I  for bm 12, 
C57BL/6,  and  an  appropriate  responder or  nonresponder  strain  for each  antigen. 
With (T,G)-A--L, both C57BL/6 and bml2  showed a  high response with mean titers 
of  1:320  and  1:640,  respectively.  Similarly,  both  strains  gave  a  high  response  to 
(Phe,G)-A--L, with  mean titers of 1:256,  for C57BL/6  and  1:432, for bm 12.  Neither 
C57BL/6  nor bml2  showed any response to (H,G)-A--L (Table I). There was clearly 
no difference in the response of C57BL/6  and bm 12 to any of the antigens. 
Comparison of Tc  to  H-Y in  C57BL/6  and bml2.  C57BL/6  females  produced  an 
effective cytotoxic response against male ConA blast cells (Fig.  1), with 30% cell lysis 
at  a  25:1  effector:target cell  ratio;  no  lysis of C57BL/6  female  cells was  detected, 
indicating that the response was H-Y specific. By contrast, bm 12 females were unable 
to  make  any  H-Y  cytotoxic  response,  and  the  results  of  Fig.  1  have  now  been 
reproduced on several occasions. The defect lay in the ability of bm 12 to respond to 
H-Y and not in the expression of the antigen, as female C57BL/6  mice, primed with 
C57BL/6 male cells could also lyse bm 12 male cells and C57BL/6 male cells (Fig.  1). 
Furthermore, there is no intrinsic problem in the bm 12 strain in the proliferation and 
generation  of Tc,  for  bml2  can  respond  to  an  H-2  or I-A  difference  as  indicated 
elsewhere ([1]; K. Melief, personal communication; and our unpublished results). For 
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TABLE  I 
Antibody Response to (T,G)-A--L,  (Phe, G)-A--L, and (H,G)-A--L * 
Antigen  C57BL/6  B6.C-H-2  bm12  BI0.BR  BI0.S 
(T,G)-A--L  80, 80, 160, 320, 320, 320,  160,  160,  320,  320,  320,  <5, <5, <5, <5, <5, <5,  NT 
320,320,640,640  640, 640,  1,280,  1,280,  <5,<5,<5,<5 
i ,280 
(320 ±  62)  (640 ±  149)  (0) 
(Phe,G)-A--L  160, 160,  160, 320, 320  80, 160, 640, 640, 640  NT  (0) 
(256 ±  39)  (432 ±  128) 
(H,G)-A--L  <5, <5, <5, <5, <5  <5, <5, <5, <5, <5  160, 320, 320, 320 624  NT 
(0)  (0)  (352 ±  78) 
The titers were calculated as the dilution of serum which gave greater than or equal to four times the background counts 
(400 cpm). The background was ~90 cpm and the maximum cpm ranged from 8,000 to 26,000 in the different mice. The 
reciprocal titers are shown and the mean ±  SEM in parentheses. NT, not tested. 
cells as described above. In addition, priming was also done by skin grafting, grafting 
plus lymphocyte injection and by cell injection into the footpads--all with the same 
result:  bml2 was unable to generate Tc to the H-Y antigen. 
Generation of Tc in an F1 Hybrid Using the Two Nonresponder  Strains bm 12 and B I O.A.  As 
bm 12 was clearly a nonresponder to the H-Y antigen--a response which must now be 
considered to be influenced by Ia-1 gene, as this is the site of the mutation in bml2-- 
we  determined  whether  there  were  any  circumstances  under  which  bml2  could 
respond to the H-Y antigen, particularly as other studies had indicated the presence 
of complementary Ir genes for H-Y in several H-2 haplotypes. Thus, two nonresponder 
strains, bm 12 and B 10.A, were examined in the F1 hybrid for the generation of Tc to 
the H-Y antigen. Female F1 hybrid mice, primed in vivo and then stimulated in vitro 
with  bml2  male cells,  were able to  lyse both bml2  and  C57BL/6,  but  not  B10.A 
male ConA blast cells  (Fig.  2 A). The response was specific for the H-Y antigen  as 
bml2 female cells could not be lysed (Fig.  2).  C57BL/6 and bml2 could be lysed as 
they share the appropriate associative target H-2 antigen--H-2D  b in this case--with 
the priming cell. B 10.A (H-2Kk,D  d) does not have the appropriate associative antigen 
and was not lysed (8, 9), nor could it stimulate an anti-H-Y cytotoxic response in Fa 
female  mice  that  had  been  primed  with  bml2  male  cells  (Fig.  2B).  The  results 
demonstrate the presence of complementary Ir genes in bml2 and BI0.A. 
Discussion 
The results demonstrate, unequivocally, that a  mutation in the Ia-1  gene in the/- 
A subregion has affected one immune response (Ir) gene, but has not affected those Ir 
genes responsible for the antibody response to  (T,G)-A--L and  (Phe,G)-A--L. Thus, 
the  preliminary  analysis  has  led  us  to conclude  that  the  gene(s)  coding  for the  Ia 
specificities (detected serologically) and at least one Ir gene may be the same, but that 
this does not apply to all/r genes and under all circumstances.  (T,G)-A--L, (Phe,G)- 
A--L, and  (H,G)-A--L were selected  for initial  study as they are well-characterized 
antigens, the responses to which are under the control of Ir genes that map in the I-A 
subregion (3, 6, 7). Furthermore, anti-Ia sera have been noted to block the proliferative 
response to (T,G)-A--L (10)  and this and other evidence has led to much speculation 
on the relationship of Ir genes and Ia antigens--in particular of It-1  [which controls 
the  response  to  (T,G)-A--L]  and  Ia-/b  [which  codes  for  the  la  b  specificities  Ia- MICHAELIDES  ET  AL.  BRIEF  DEFINITIVE  REPORT  467 
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Fro.  I.  Anti-H-Y cyytotoxic responses ofC57BL/6 (A) and B6.C-H-2  bin12 (B) female mice, primed 
in vivo and boosted in vitro with syngeneic male spleen cells. The target cells used were: C57BL/6 
male (×) and female (©) cells; and B6,C-H-2  bin12 male (0) and female (A) cells. 
3,8,9,15,20].  In addition, the response to (H,G)-A--L was examined; this was done as 
it was considered possible that an Ir gene mutation could lead to the conversion of a 
nonresponder  to a  responder strain,  and  also as it  has been suggested  (3)  that  the 
(T,G)-A--L and (H,G)-A--L responses are governed by allelie genes at the one locus. 
However, both C57BL/6  and bml2 were good responders  to both  (T,G)-A--L and 
(Phe,G)-A--L and nonresponders to (H,G)-A--L. In addition,  the T  cell proliferative 
responses to these antigens  appear to be similar  (data not  shown)  and  preliminary 
studies have not shown any differences in either the antibody or proliferative response 
to ovalbumin  or  to  glutamine-alanine-tyrosine  (GAT).  Can  we  therefore conclude 
that  Ir-1  for (T,G)-A--L and Ir-  (Phe,G)-A--L genes are not  the same as Ia-l?  The 
answer is yes, but with several qualifications:  First,  the immunizing dose should be 
considered,  as  sufficiently  low  doses  of antigen  are  critical  in  demonstrating  the 
presence of Ir genes (12).  Although it cannot be excluded that other doses of antigen 
may have given different  results,  the doses used could clearly differentiate between 
high and nonresponders for the three antigens used (Table I). Secondly, it is possible 
that Ir gene products and Ia alloantigens are expressed on different sites of the one 
glycoprotein chain and the mutation has altered one site but  not the other.  This is 
possible, but  unlikely  as there  appears to be a  gross disturbance  in  the  Ia-bearing 
chain,  as demonstrated  serologically, and biochemically with both alloantisera and 
xenoantisera  (M.  Sandrin,  I.  F.  C.  McKenzie,  and  R.  W.  Melvold.  Manuscript  in 
preparation.). In addition, the response to the H-Y antigen has been altered (Fig.  1). 
At this time, with the evidence presented herein (Table I), we must conclude that the 
Ia-1  and Ir-I[(T,G)-A--L],[Ir-(Phe,G)-A--L]  genes are separate structures.  Whether 
this applies to other soluble polypeptide antigens is currently under investigation with 
a large series of antigens. 
By contrast to the foregoing, the immune response to H-Y is clearly altered in the 
bml2 mutant strain and at least for this antigen we can state that it is likely that Ir- 
H-Y and  Ia-1  are the same.  However, the  immune response to  the  H-Y antigen  is 
complex and different  aspects of the immune response appear to be under separate 
(unrelated?)  gene control. For example, skin graft rejection and delayed-type hyper- 
sensitivity responses are effected by a gene mapping in the I-B subregion ([ 12]; and F. 468 
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Fro.  2.  Anti-H-Y cytotoxic  responses of C57BL/6  and  (B10.A ×  B6.C-H-2bmI2)Fa  mice.  (B10.A 
×  B6.C-H-2bm12)FI  female mice, primed in vivo with B6.C-H-2 b~12 male cells, were stimulated in 
vitro with the priming cells (A) or with BI0.A male cells (B). C57BL/6 female mice (C) were primed 
and boosted as described in Fig.  1. Cytotoxic effector cells were assayed against various target cells: 
B6.C-H-2 bmI~ male (×) and female (A) cells: C57BL/6 male (O) and female (<>) cells; and BI0.A 
male (O) and female cells (l~). 
Liew and  E.  Simpson.  Personal  communication.),  whereas  the  generation  of Tc  is 
under the control of an I-A  subregion gene  (4)  (which now appears to be identical 
with Ia-l). There are also other genes, (i.e., complementary Ir genes), which in other 
haplotypes have been found  elsewhere within  H-2,  e.g.  in  IC ~ (8).  In  addition  the 
appropriate associative H-2K or H-2D antigen must be present for Tc to be detected. 
When  these  conditions  are  satisfied,  bml2  is  clearly  a  nonresponder  and  has  an 
alteration in the It-H- Y gene. The defect produced by the mutation is in the response, 
and is clearly not present in the expression or presentation of the H-Y antigen.  But 
how this defect is manifest or how the It-H- Y gene product is expressed is not clear at 
present. The ability of the two nonresponder strains bm 12 and B 10.A to complement 
each other to generate Tc is of interest  and indicates,  in bml2, that other Ir genes 
exist which also effect the generation of Tc to H-Y. 
Summary 
The B6.C-H-2  bin12 (bml2) strain has a mutation in the I-A subregion of the murine 
H-2 complex and is characterized by a  loss of serologically detected Ia antigens and 
a strong graft rejection and mixed lymphocyte response between parent and mutant. 
It  was  presumed  that  the  mutation  affected  the  Ia-I  gene  and  to  determine  the 
relationship of Ia antigens and Ir genes, the immune responses of mutant and parent 
were compared. The immune responses to poly(LTyr,LGlu)-poly(vLAla)--poly(LLys), 
poly(Phe,Glu)-poly(DLAla)--poly(LLys),  and  poly(His,Glu)-poly(DLAla)--poly(LLys) 
in parent and mutant were the same, indicating that Ia-i and the Ir genes for these 
antigens are not identical.  By contrast, although C57BL/6 gave a good response, the 
mutant strain was unable to generate cytotoxic T  lymphocytes to the male-specific H- 
Y  antigen--a  response  under  I-A  subregion  Ir  gene  control,  which  now  must  be 
considered  to  be  the  Ia-1  gene.  In  addition,  complementary Ir  genes  in  the  //-2  b 
haplotype for the H-Y immune response could be detected when the bml2 mutant 
was used. MICHAELIDES ET AL.  BRIEF DEFINITIVE REPORT  469 
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